NAT10-Mediated N4-Acetylcytidine: A Key Regulator of Mouse Oocyte Maturation In Vitro

Study Background and Research Question

Messenger RNA (mRNA) modifications are increasingly recognized as crucial layers of post-transcriptional gene regulation, modulating processes such as mRNA stability, translation, and cellular differentiation. Among over 170 RNA modifications identified to date, N4-acetylcytidine (ac4C) has emerged as a notable epitranscriptomic marker influencing mRNA stability and translation efficiency. However, the functional contribution of ac4C to mammalian oocyte maturation—a process governed predominantly by post-transcriptional mechanisms—remained unexplored prior to this study (paper). The research conducted by Xiang et al. sought to address a fundamental question in reproductive biology: Does NAT10-mediated ac4C modification play a regulatory role in mouse oocyte maturation in vitro, and if so, through what molecular mechanisms?

Key Innovation from the Reference Study

The central innovation of this work lies in the identification of NAT10, the sole known mammalian ac4C "writer" enzyme, as a critical determinant of oocyte maturation. The study provides evidence that both ac4C levels and NAT10 expression decrease during the transition from immature to mature mouse oocytes. By employing siRNA-mediated knockdown of NAT10 in germinal vesicle (GV)-stage oocytes, the authors demonstrate a direct link between reduced ac4C modification and impaired meiotic progression, specifically in the extrusion of the first polar body—a key marker of oocyte maturation (paper).

Methods and Experimental Design Insights

The research integrates molecular, cellular, and bioinformatic approaches to dissect the role of ac4C in oocyte maturation:

• Expression Analysis: Quantitative assessment of NAT10 and ac4C levels in mouse oocytes at different maturation stages revealed a significant downward trend from the GV to the metaphase II (MII) stage.
• NAT10 Knockdown: Small interfering RNA (siRNA) was microinjected into GV-stage oocytes to specifically silence NAT10 expression. Control oocytes were either non-transfected or transfected with negative control siRNA.
• Functional Assays: The impact of NAT10 knockdown was evaluated by measuring the rates of germinal vesicle breakdown (GVBD) and first polar body extrusion—standard indicators of meiotic progression in vitro.
• Transcriptomic Profiling: RNA immunoprecipitation (RIP) combined with high-throughput sequencing in HEK293T cells enabled the identification of ac4C-modified transcripts and downstream gene networks affected by NAT10 perturbation.
• Protein Interactome Analysis: Bioinformatic prediction and RNA pulldown experiments were used to propose TBL3 as a potential ac4C-binding protein, implicating it in the downstream mediation of ac4C-modified RNA functions.

Protocol Parameters

• assay | siRNA microinjection (GV-stage oocytes) | ~10–20 pL (per oocyte) | Used for efficient gene knockdown in single oocytes | Standard for functional gene interrogation in oocyte biology | paper
• assay | RNA immunoprecipitation (RIP) | 1–2 μg antibody per 100 μg lysate | Isolates ac4C-modified RNAs for sequencing | Ensures specificity for modified transcript enrichment | paper
• assay | In vitro maturation (IVM) culture | 24–48 h at 37°C, 5% CO₂ | Supports meiotic progression of murine oocytes in vitro | Mimics physiological maturation conditions | paper
• assay | T7 RNA polymerase transcription | 1–2 μg DNA template, 20 μL reaction | For in vitro synthesis of modified/capped RNAs | Facilitates studies of RNA modification and function | workflow_recommendation

Core Findings and Why They Matter

NAT10 and ac4C levels were shown to decline as mouse oocytes mature from the GV to MII stage. Crucially, targeted depletion of NAT10 by siRNA did not alter the rate of GVBD (p = 0.6531) but dramatically reduced the rate of first polar body extrusion (34.6% in NAT10-knockdown oocytes vs. 74.6% in controls; p < 0.001) (paper). This indicates that ac4C modification, mediated by NAT10, is dispensable for meiotic resumption but essential for successful completion of meiosis I. Transcriptomic analysis of ac4C-modified RNAs suggested that NAT10-regulated mRNAs are enriched in pathways related to chromatin assembly, silencing, and cytoskeletal anchoring. These findings position ac4C as a key modulator of oocyte chromatin dynamics and cytoskeletal reorganization—processes vital for the developmental competence of female gametes. The identification of TBL3 as a putative ac4C "reader" protein provides a preliminary mechanistic link to how ac4C-modified RNAs may exert their regulatory effects post-transcriptionally. While TBL3's role remains to be fully validated, this hypothesis-generating approach paves the way for future studies of ac4C signaling networks.

Comparison with Existing Internal Articles

Recent internal discussions have highlighted the importance of high-yield, robust in vitro transcription workflows for the study and manipulation of RNA modifications. For instance, the article "Translating Mechanistic RNA Insights into Action: High-Yield In Vitro Transcription" underscores how advanced in vitro transcription RNA kits, such as the HyperScribe™ T7 High Yield RNA Synthesis Kit, facilitate the synthesis of modified RNAs for post-transcriptional regulation research. The capacity to generate capped, biotinylated, or otherwise chemically modified RNAs enables researchers to model and interrogate specific epitranscriptomic marks, such as ac4C, in controlled settings (internal). Furthermore, the article "Revolutionizing Epitranscriptomic RNA Workflows" discusses the synergy between T7 RNA polymerase transcription and the study of RNA modifications—highlighting that such workflows are indispensable for dissecting the functional consequences of modifications like ac4C in developmental biology and RNA vaccine research.

Limitations and Transferability

While the findings robustly link NAT10-mediated ac4C to oocyte maturation in vitro, several limitations are noteworthy:

• Species and Context Specificity: The study is restricted to mouse oocytes and in vitro maturation protocols. The extent to which these mechanisms operate in human oocytes or in vivo remains undetermined (paper).
• Functional Redundancy: Although NAT10 is the only known ac4C "writer" in mammals, the involvement of compensatory or parallel epitranscriptomic pathways cannot be excluded.
• Direct Mechanistic Links: The functional contribution of candidate ac4C-binding proteins, such as TBL3, awaits further experimental validation.

Transferability to other domains, such as RNA vaccine research or RNA interference experiments, depends on the functional conservation of ac4C-mediated regulation across cell types and organisms—a topic for further investigation.

Research Support Resources

For researchers aiming to study RNA modifications or generate high-yield, chemically modified transcripts for post-transcriptional regulation studies, the HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU K1047, APExBIO) offers a streamlined solution. This kit enables efficient T7 RNA polymerase transcription for applications such as capped RNA synthesis, biotinylated RNA synthesis, and in vitro synthesis of modified RNAs—supporting workflows in RNA biology, RNA vaccine research, and RNA interference experiments (workflow_recommendation; product_spec). By providing all necessary components for rapid in vitro transcription, the HyperScribe™ kit can facilitate the experimental modeling of RNA modifications, including those relevant to oocyte biology and epitranscriptomic studies. This resource may be particularly valuable for researchers seeking to recapitulate or extend the findings of NAT10-mediated ac4C regulation in mouse oocytes or other cellular systems.